Two Sigma Investments, LP Voyager Therapeutics, Inc. Transaction History

Two Sigma Investments, LP

$42.3 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$7.15 - $10.84 $85 - $130	12 Added 0.05%	22,112 $205,000
Q4 2023 Feb 14, 2024	SELL	$6.28 - $8.81 $72,220 - $101,315	-11,500 Reduced 34.23%	22,100 $186,000
Q3 2023 Nov 14, 2023	SELL	$7.55 - $11.25 $179,652 - $267,693	-23,795 Reduced 41.46%	33,600 $260,000
Q2 2023 Aug 14, 2023	BUY	$6.94 - $13.99 $217,881 - $439,216	31,395 Added 120.75%	57,395 $657,000
Q1 2023 May 15, 2023	BUY	$6.0 - $10.78 $156,000 - $280,280	26,000 New	26,000 $200,000
Q2 2022 Aug 15, 2022	SELL	$4.82 - $10.09 $303,804 - $635,972	-63,030 Reduced 65.35%	33,427 $198,000
Q1 2022 May 16, 2022	BUY	$2.75 - $9.44 $265,256 - $910,554	96,457 New	96,457 $735,000
Q3 2021 Nov 15, 2021	SELL	$2.63 - $4.12 $35,397 - $55,451	-13,459 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$3.94 - $5.44 $1.24 Million - $1.71 Million	-313,535 Reduced 95.88%	13,459 $56,000
Q1 2021 May 17, 2021	BUY	$4.61 - $9.04 $1.51 Million - $2.96 Million	326,994 New	326,994 $1.54 Million
Q1 2020 May 15, 2020	SELL	$6.8 - $14.66 $488,899 - $1.05 Million	-71,897 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$12.82 - $16.85 $51,703 - $67,956	-4,033 Reduced 5.31%	71,897 $1 Million
Q3 2019 Nov 14, 2019	BUY	$16.31 - $28.29 $462,209 - $801,710	28,339 Added 59.55%	75,930 $1.31 Million
Q2 2019 Aug 14, 2019	BUY	$19.18 - $27.88 $912,795 - $1.33 Million	47,591 New	47,591 $1.3 Million
Q1 2019 May 15, 2019	SELL	$8.0 - $19.66 $1.12 Million - $2.76 Million	-140,536 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$8.59 - $18.05 $472,922 - $993,742	55,055 Added 64.41%	140,536 $1.32 Million
Q3 2018 Nov 14, 2018	BUY	$17.11 - $21.74 $1.46 Million - $1.86 Million	85,481 New	85,481 $1.62 Million
Q2 2018 Aug 14, 2018	SELL	$16.76 - $23.92 $286,596 - $409,032	-17,100 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$16.16 - $31.31 $276,336 - $535,401	17,100 New	17,100 $321,000

Others Institutions Holding VYGR

# of Institutions

130

Shares Held

34.7M

Call Options Held

39.7K

Put Options Held

34.6K

Black Rock Inc. New York, NY

5.31M
Shares

$30.7 Million
0.0% of portfolio
Armistice Capital, LLC New York, NY

5.2M
Shares

$30.1 Million
0.5% of portfolio
Eco R1 Capital, LLC San Francisco, CA

3.92M
Shares

$22.6 Million
0.99% of portfolio
Vanguard Group Inc Valley Forge, PA

3.19M
Shares

$18.4 Million
0.0% of portfolio
Farallon Capital Management LLC San Francisco, CA

2.29M
Shares

$13.2 Million
0.07% of portfolio

View Full List

About Voyager Therapeutics, Inc.

Ticker VYGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,647,600
Market Cap $223M
Description
Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...

More about VYGR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Account